Skip to content

LETKO, BROSSEAU & ASSOCIATES INC: EMA position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of LETKO, BROSSEAU & ASSOCIATES INC on EMA, newest first. How the timeline and the estimate are built.

LETKO, BROSSEAU & ASSOCIATES INC held 8,485 EMA shares at 2026-06-30 per its 13F-HR filed 2026-08-13.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 8,485 shares
    Change vs previous 13F 0 shares

    0.01% of the 13F portfolio, value $449,922.

    13F-HR 0001297496-26-000007 filed by LETKO, BROSSEAU & ASSOCIATES INC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 8,485 shares
    Change vs previous 13F 0 shares

    0.01% of the 13F portfolio, value $438,432.

    13F-HR 0001297496-26-000005 filed by LETKO, BROSSEAU & ASSOCIATES INC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 8,485 shares
    Change vs previous 13F 0 shares

    0.01% of the 13F portfolio, value $418,694.

    13F-HR 0001297496-26-000003 filed by LETKO, BROSSEAU & ASSOCIATES INC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 8,485 shares
    Change vs previous 13F 0 shares

    0.01% of the 13F portfolio, value $407,175.

    13F-HR 0001297496-25-000024 filed by LETKO, BROSSEAU & ASSOCIATES INC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 8,485 shares
    Change vs previous 13F not available

    0.01% of the 13F portfolio, value $387,903.

    13F-HR 0001297496-25-000022 filed by LETKO, BROSSEAU & ASSOCIATES INC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).